ACM
AGRX

Aquatic Capital Management’s Agile Therapeutics AGRX Stock Holding History

Aquatic Capital Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-74
Closed -$1K – 1937
2022
Q3 		$1K Buy
+74
New +$1.82K ﹤0.01% 1128
2022
Q2 		– Sell
-1
Closed – – 1685
2022
Q1 		$0 Sell
1
-1
-50% -$638 ﹤0.01% 1639
2021
Q4 		$2K Buy
+2
New +$2.82K ﹤0.01% 1064

Other funds holding AGRX

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Aquatic Capital Management's AGRX Position: Q4 2022 in Review

Aquatic Capital Management sold out of Agile Therapeutics (AGRX) in Q4 2022, closing a stake of 74 shares — an estimated $1K sold.

Aquatic Capital Management first reported a position in AGRX in Q4 2021 and held it in 3 quarters. The position peaked at $2K in Q4 2021. 26 funds tracked by Wall St. Rank hold AGRX as of Q4 2022.

  • Aquatic Capital Management reported no remaining Agile Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 74 Agile Therapeutics shares in Q4 2022, an estimated $1K.
  • Aquatic Capital Management first reported a position in Agile Therapeutics in Q4 2021 and held it in 3 quarters.
  • Aquatic Capital Management's Agile Therapeutics position peaked at $2K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.